All News

My experience with small lymphocytic lymphoma for the past 16 years has taught me many lessons.

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to patients with cancer, Dr. Natalie Berger said.

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path.

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health during treatment.

Research shows lifestyle and gut bacteria may drive early-onset colorectal cancer, emphasizing diet and healthy habits to help lower risk.

Learn about inflammatory breast cancer (IBC) diagnosis, aggressive treatment paths, and side effects to better navigate your journey and care plan.

Dr. Robert Coleman explains how Lifyorli plus nab-paclitaxel may help patients with platinum-resistant ovarian cancer control disease and improve survival.

If a car had a 50% chance of crashing, I would never let my son in it. With a hereditary cancer syndrome, though, there's no safety feature to lessen the odds. The mutation is simply there, or it isn't.

Dr. Gregory Tiesi discusses TAMP, a targeted therapy that delivers chemotherapy directly to pancreatic tumors with fewer side effects.

CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating development for patients with few options.

New research shows adults over 80 with early-stage lung cancer can achieve surgical outcomes and quality of life comparable to younger patients.

Cogent submitted an FDA application for bezuclastinib after the phase 3 PEAK trial shows improved progression-free survival in patients with previously treated GIST.

Although I know better, I gardened in a sleeveless shirt and ended up with a poison ivy rash on my lymphedema limb. This time, I was lucky. Hopefully I will follow my own advice and avoid tempting fate next time.

Nurse Bridget Hopkins shares how she navigates metastatic breast cancer through second opinions, "YOLO" trips and the power of advanced care planning.

The phase 3 EMERALD-3 trial shows Imfinzi and Imjudo plus Lenvima and embolization improved progression-free survival in unresectable liver cancer.

The FDA fully approved Tecartus for adult patients with relapsed or refractory mantle cell lymphoma based on high response rates in the ZUMA-2 trial.

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care without invasive surgery.

A study found blood-based genomic testing can be completed in 27 hours, giving patients with cancer faster treatment decisions.

Eleven years with Stage 4 breast cancer, all on the first line of treatment. It isn’t chronic, but what is it?

Multiple myeloma survivor JP Kealy and wife Annamarie share how to avoid cancer burnout and why this journey is a marathon, not a sprint.

A phase 3 trial finds anbenitamab and docetaxel improve response rates in patients with HER2-positive breast cancer and offer a safer delivery.

A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with self-care.

New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients with lung cancer.

Author and multiple myeloma survivor Jonathan Gluck shares how an unexpected diagnosis reshaped his identity and approach to living with uncertainty.

The 49th Annual Miami Breast Cancer Conference recently hosted a cornerstone event for the advocacy community: the CURE Educated Patient® Breast Cancer Summit.

Dr. Susan MacDonald, a urologist who has been diagnosed with stage 4 breast cancer, launches a new vlog series for CURE, “Demystifying the Darkness.”

Eight patients with NSCLC treated with ateganosine plus Libtayo had over 2-year survival after prior therapies, based on phase 2 THIO-101 trial data.

Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is missing.